The long-term safety and efficacy of omalizumab, alongside promising phase 3 trial results that demonstrated the efficacy and ...

Urticaria highlights from AAD 2025 include late-breaking results from a phase 1b/2a study of the anti-c-Kit antibody ...

MANILA, Philippines — Former television host and actress Kris Aquino revealed that she now has a total of nine autoimmune ...

Urticaria or hives is a skin condition causing itchy red welts from various triggers Read ahead know its symptoms and why it often worsen at night ...

Loratadine, a widely prescribed second-generation antihistamine, is commonly used to treat allergic conditions such as hay ...

Loratadine is a second-generation antihistamine drug for the treatment of allergic diseases including allergic rhinitis and ...

Kris Aquino revealed that she is now diagnosed with nine autoimmune diseases. On Instagram, the Queen of All Media said that ...

Novartis is just months away from filing for approval of oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria – also known as chronic hives – after reporting long ...

Morepen Laboratories receives approval for Loratadine API in China, paving the way for significant market expansion and growth opportunities.

Morepen Laboratories approved for Loratadine export to China, aiming to strengthen global position in anti-allergy API market.